Close

Zynerba Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights May 15, 2023 07:00AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 28, 2023 07:30AM
Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights Mar 28, 2023 07:30AM
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights Nov 14, 2022 07:30AM
Zynerba Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights Nov 14, 2022 07:30AM


Aug 10, 2022 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
Aug 10, 2022 07:00AM Zynerba Pharmaceuticals Reports Second Quarter 2022 Financial Results and Operational Highlights
Aug 3, 2022 07:00AM Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
Aug 3, 2022 07:00AM Zynerba Pharmaceuticals to Present In Person at the Canaccord Genuity 42nd Annual Growth Conference
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
May 16, 2022 07:00AM Zynerba Pharmaceuticals Reports First Quarter 2022 Financial Results and Operational Highlights
Aug 4, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
Aug 4, 2021 07:30AM Zynerba Pharmaceuticals to Present at the Canaccord Genuity 41st Annual Growth Conference
May 12, 2021 06:45AM Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights
May 12, 2021 06:45AM Zynerba Pharmaceuticals Reports First Quarter 2021 Financial Results and Operational Highlights
Mar 10, 2021 06:45AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Mar 10, 2021 06:45AM Zynerba Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Operational Highlights
Aug 10, 2020 06:45AM Zynerba Pharmaceuticals Reports Second Quarter 2020 Financial Results and Operational Highlights
Aug 6, 2020 07:00AM Zynerba Pharmaceuticals to Present at the Virtual 40th Annual Canaccord Genuity Growth Conference
Jul 31, 2019 08:00AM Zynerba Pharmaceuticals to Present at Two Upcoming Conferences
Apr 22, 2019 07:13AM Canaccord Genuity Transfers Coverage on Zynerba Pharmaceuticals (ZYNE) at Buy
Aug 1, 2018 08:46AM Zynerba Pharmaceuticals to Present at the 38th Annual Canaccord Genuity Growth Conference
Dec 4, 2017 05:54AM Zynerba Pharmaceuticals (ZYNE) PT Raised to $18 at Canaccord Genuity
Sep 28, 2017 01:43PM UPDATE: Zynerba Pharmaceuticals (ZYNE) PT Raised to $15 at Canaccord Genuity
Aug 3, 2016 07:00AM Zynerba Pharmaceuticals to Present at Canaccord Genuity’s 36th Annual Growth Conference
Sep 16, 2015 08:45AM Canaccord Genuity Reiterates Buy on Zynerba Pharma (ZYNE) Following GW Pharmaceutical's (GWPH) Positive CBD Data
Sep 14, 2015 08:29AM Canaccord Genuity Starts Zynerba Pharmaceuticals (ZYNE) at Buy
Aug 10, 2015 11:41AM Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
Aug 10, 2015 11:41AM Zynerba Pharmaceuticals Announces Closing of Its Initial Public Offering and Exercise in Full of Option to Purchase Additional Shares
Aug 5, 2015 10:54AM Zynerba Pharmaceuticals (ZYNE) IPO Opens Up 29% Higher
Aug 4, 2015 05:58PM Zynerba Pharmaceuticals (ZYNE) Prices 3M Common Stock IPO at $14/Share
Aug 4, 2015 05:57PM Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering
Aug 4, 2015 05:57PM Zynerba Pharmaceuticals Announces Pricing of Its Initial Public Offering
Jun 30, 2015 12:24PM Zynerba Pharmaceuticals (ZYNE) Files $57.5M Common Stock IPO